Global Lipid-Lowering Therapy Market By Drug Type (Statins – Atorvastatin (Lipitor), Cerivastatin (Baycol), Fluvastatin (Baycol), Lovastatin (Mevacor), Pravastatin (Pravachol), Simvastatin (Zocor), Others, Bile acid sequestrants, Niacin, Icosapent ethyl, Bempedoic acid, PCSK9 Inhibitors, Others); By Route or administration (Oral, Subcutaneous); By Age Group (55 years or younger, 56 – 60 years, 61 – 65 years, 66 – 70 years, 71- 75 years, older than 75 years); By Region (U.S., Canada, Mexico, Rest of North America, France, UK, Germany, Spain, Italy, Nordic Countries, Benelux Union, Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Rest of Asia Pacific, Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of MEA, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2022 – 2030